Seroprevalence of coxsackievirus A16 antibody among people of various age groups: a systematic review and meta-analysis
Abstract Background Coxsackie virus group A type 16 (CoxA16) is the main pathogen and usually an alternative to or joins in prevalence with enterovirus 71 (EV71) causing hand, foot and mouth disease (HFMD). The objective of this study was to estimate the seroprevalence of CoxA16 antibody among peopl...
Saved in:
Main Authors: | Peng Li (Author), Yan Chen (Author), An Tang (Author), Fan Gao (Author), Jian-Bo Yan (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge
by: Ruixiao Du, et al.
Published: (2019) -
CLINICAL EPIDEMIOLOGICAL PECULIARITIES OF ENTEROVIRUS COXSACKIEVIRUS A16 GROUP MORBIDITY IN CHILDREN
by: L. A. Lityaeva, et al.
Published: (2015) -
Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo
by: Xin Yao, et al.
Published: (2018) -
A surrogate assay for measuring Coxsackievirus A6 neutralizing antibodies
by: Yao Su, et al.
Published: (2018) -
A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccine
by: Bopei Cui, et al.
Published: (2021)